11 research outputs found
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA)
Intra-abdominal infections (IAI) are an important cause of morbidity and are frequently associated with poor prognosis, particularly in high-risk patients. The cornerstones in the management of complicated IAIs are timely effective source control with appropriate antimicrobial therapy. Empiric antimicrobial therapy is important in the management of intra-abdominal infections and must be broad enough to cover all likely organisms because inappropriate initial antimicrobial therapy is associated with poor patient outcomes and the development of bacterial resistance. The overuse of antimicrobials is widely accepted as a major driver of some emerging infections (such as C. difficile), the selection of resistant pathogens in individual patients, and for the continued development of antimicrobial resistance globally. The growing emergence of multi-drug resistant organisms and the limited development of new agents available to counteract them have caused an impending crisis with alarming implications, especially with regards to Gram-negative bacteria. An international task force from 79 different countries has joined this project by sharing a document on the rational use of antimicrobials for patients with IAIs. The project has been termed AGORA (Antimicrobials: A Global Alliance for Optimizing their Rational Use in Intra-Abdominal Infections). The authors hope that AGORA, involving many of the world's leading experts, can actively raise awareness in health workers and can improve prescribing behavior in treating IAIs
WSES Guidelines for the management of acute left sided colonic diverticulitis in the emergency setting
Acute left sided colonic diverticulitis is one of the most common clinical conditions encountered by surgeons in acute setting. A World Society of Emergency Surgery (WSES) Consensus Conference on acute diverticulitis was held during the 3rd World Congress of the WSES in Jerusalem, Israel, on July 7th, 2015. During this consensus conference the guidelines for the management of acute left sided colonic diverticulitis in the emergency setting were presented and discussed. This document represents the executive summary of the final guidelines approved by the consensus conference.Peer reviewe
WSES guidelines for management of Clostridium difficile infection in surgical patients
In the last two decades there have been dramatic changes in the epidemiology of Clostridium difficile infection (CDI), with increases in incidence and severity of disease in many countries worldwide. The incidence of CDI has also increased in surgical patients. Optimization of management of C difficile, has therefore become increasingly urgent. An international multidisciplinary panel of experts prepared evidenced-based World Society of Emergency Surgery (WSES) guidelines for management of CDI in surgical patients.Peer reviewe
Enteroparasitas e Capillaria SP entre o grupo Surui, Parque Indigena Aripuana, Rondonia Enteroparasites and Capillaria SP found in indians of the Surui group, Parque Indigena Aripuana, Rondonia
Este trabalho apresenta dados de enteroparasitas encontradas em Ăndios da comunidade tribal de SuruĂ, em RondĂŽnia, na RegiĂŁo AmazĂŽnica do Brasil. As seguintes espĂ©cies foram encontradas: Ascaris lumbricoides (53,3%), Ancilostomidae (43,3%), Strongyloides stercoralis (33,3%), Taenia sp. (5,8%), Trichuris trichiura (5,0%), Hymenolepis nana (4,1%), Giardia lamblia (3,3%), Entamoeba histolytica complex (0,8%) e Enterobius vermicularis (0,1%). O encontro de Capillaria sp. nas fezes de dois individuos Ă© discutido.<br>In this paper data on enteroparasites found in indians of the Surui tribal community in RondĂŽnia, Amazon Region of Brazil, are presented. The following species were detected: Ascaris lumbricoides (53.3%), Ancylostomidae (43.3%), Strongyloides stercoralis (33.3%), Taenia sp. (5.8%), Trichuris trichiura (5.0%), Hymenolepis nana (4.1%), Giardia lambia (3.3%), Entamoeba histolytica complex (0.8%) and Enterobius vermicularis (0.1%)
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA)
Abstract
Intra-abdominal infections (IAI) are an important cause of morbidity and are frequently associated with poor prognosis, particularly in high-risk patients.
The cornerstones in the management of complicated IAIs are timely effective source control with appropriate antimicrobial therapy. Empiric antimicrobial therapy is important in the management of intra-abdominal infections and must be broad enough to cover all likely organisms because inappropriate initial antimicrobial therapy is associated with poor patient outcomes and the development of bacterial resistance.
The overuse of antimicrobials is widely accepted as a major driver of some emerging infections (such as C. difficile), the selection of resistant pathogens in individual patients, and for the continued development of antimicrobial resistance globally. The growing emergence of multi-drug resistant organisms and the limited development of new agents available to counteract them have caused an impending crisis with alarming implications, especially with regards to Gram-negative bacteria.
An international task force from 79 different countries has joined this project by sharing a document on the rational use of antimicrobials for patients with IAIs. The project has been termed AGORA (Antimicrobials: A Global Alliance for Optimizing their Rational Use in Intra-Abdominal Infections). The authors hope that AGORA, involving many of the world's leading experts, can actively raise awareness in health workers and can improve prescribing behavior in treating IAIs